Rocket Pharmaceuticals Inc RCKT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
23.47UNCH (UNCH)
Volume
21,837
Close
23.47quote price arrow up+0.70 (+3.07%)
Volume
606,411
52 week range
14.89 - 32.53
Loading...
  • Open23.63
  • Day High24.00
  • Day Low23.30
  • Prev Close22.77
  • 52 Week High32.53
  • 52 Week High Date12/28/23
  • 52 Week Low14.89
  • 52 Week Low Date08/21/23

Key Stats

  • Market Cap2.124B
  • Shares Out90.50M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-21.69

KEY STATS

  • Open23.63
  • Day High24.00
  • Day Low23.30
  • Prev Close22.77
  • 52 Week High32.53
  • 52 Week High Date12/28/23
  • 52 Week Low14.89
  • 52 Week Low Date08/21/23
  • Market Cap2.124B
  • Shares Out90.50M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-21.69

RATIOS/PROFITABILITY

  • EPS (TTM)-2.94
  • P/E (TTM)-7.99
  • Fwd P/E (NTM)-8.71
  • EBITDA (TTM)-249.357M
  • ROE (TTM)-50.01%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)4.29%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rocket Pharmaceuticals Inc

Profile

MORE
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company. The Company is advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Its lentiviral (LV) vector-based gene therapies target hematologic diseases and consist of late-stage programs for Fanconi Anemia, a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte...
Roderick Wong M.D.
Chairman of the Board
Gaurav Shah M.D.
Chief Executive Officer, Director
Kinnari Patel Pharm.D.
President, Chief Operating Officer, Head of Research and Development
Aaron Ondrey
Chief Financial Officer, Principal Financial Officer
John Militello CPA
Principal Accounting Officer, Vice President - Finance, Senior Controller, Treasurer
Mayo Pujols
Executive Vice President, Chief Technical Officer
Martin Wilson J.D.
General Counsel, Chief Corporate Officer
Address
350 5th Ave Ste 7530
New York, NY
10118-7501
United States

Top Peers

SYMBOLLASTCHG%CHG
SANA
Sana Biotechnology Inc
10.44+0.66+6.75%
KROS
Keros Therapeutics Inc
60.57+3.47+6.08%
FUSN
Fusion Pharmaceuticals Inc
21.45-0.04-0.19%
SNDX
Syndax Pharmaceuticals Inc
22.05+0.19+0.87%
CLDX
Celldex Therapeutics Inc
42.56+1.70+4.16%